Table 3 Univariable and multivariable Cox regression models (stepwise selection) in the diabetes group for the primary outcome of all-cause mortality or heart failure hospitalisation

Clinical

Age (per 10-year increment)

1.21

(0.90–1.60)

0.202

Male sex

0.85

(0.41–1.75)

0.665

Body mass index

0.99

(0.94–1.05)

0.827

Hypertension

0.94

(0.50–1.76)

0.838

Diabetes Type

0.88

(0.28–2.84)

0.836

Smoking

0.80

(0.46–1.40)

0.436

Coronary artery disease

1.41

(0.72–2.75)

0.314

NYHA Functional Class

1.34

(0.86–2.08)

0.200

Systolic blood pressure (per 10mmHg increment)

0.86

(0.75–0.98)

0.028

§

Plasma Biomarkers

NT-proBNP (per 100pg/mL increment)

1.01

(1.00-1.02)

0.007

§

hs-TnT (per 1ng/L increment)

1.01

(1.00-1.02)

0.016

§

GDF-15 (per 100pg/mL increment)

1.02

(1.01–1.03)

0.003

§

sST2 (per 1ng/mL increment)

1.03

(1.01–1.06)

0.003

1.03

(1.00-1.06)

0.02

Gal-3 (per 1ng/mL increment)

1.06

(1.00-1.12)

0.061

 §

CMR Markers

LVEDVi (per 10mL/m² increment)

1.07

(0.99–1.15)

0.076

 §

LVMi (per 10 g/m² increment)

1.01

(0.88–1.15)

0.928

LV ejection fraction (per 5% increment)

0.89

(0.81–0.99)

0.031

§

GLS (per 1% increment)

1.15

(1.06–1.25)

0.001

1.12

(1.03–1.21)

0.01

Presence of LGE

1.42

(0.69–2.92)

0.342

Native T1 (per 10ms increment)

1.07

(1.00-1.14)

0.04

§

ECV (per 1% increment)

1.06

(0.98–1.15)

0.139